Blebbistatin
CAS No. 674289-55-5
Blebbistatin( (±)-Blebbistatin )
Catalog No. M24685 CAS No. 674289-55-5
Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 74 | In Stock |
|
| 2MG | 42 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 126 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 369 | In Stock |
|
| 100MG | 556 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBlebbistatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBlebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
-
DescriptionBlebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing. Furthermore it preserves cell junctional integrity and barrier function.
-
In Vitro——
-
In VivoAnimal Model:New Zealand white rabbits (16-20 weeks; 3-3.5 kg) Dosage:0.05 mL; 20 μM Administration:Intracameral injection; daily; for 6 days Result:Resulted in significant improvement of corneal clarity and corneal edema resolution, implying the restoration of an intact corneal endothelial monolayer.
-
Synonyms(±)-Blebbistatin
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
Recptornon-muscle myosin II ATPases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number674289-55-5
-
Formula Weight292.33
-
Molecular FormulaC18H16N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 23 mg/mL (78.67 mM; Need ultrasonic)
-
SMILESCc(cc1)cc(C(C2(CC3)O)=O)c1N=C2N3c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ho WT, et al. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J Mol Med (Berl). 2019 Sep;97(9):1345-1357.
molnova catalog
related products
-
Fenbufen
Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class.
-
PK095
PK095 is a proprietary compound in the guanidine - based F1F0-ATPase inhibitor family.
-
Lycorine
Lycorine inhibits?protein synthesis and may inhibit?ascorbic acid?biosynthesis, although studies on the latter are controversial and inconclusive.
Cart
sales@molnova.com